The objective of this paper was to determine the incidence of leukemoid rea
ction and to evaluate its relationship with maternal and neonatal factors i
n extremely low-birth-weight (ELBW) infants. The design a case-controlled r
etrospective study of all live-born ELBW infants (<1000 g) over a period of
2 years, from July 1994 to June 1996. A total of 60 preterm infants were b
orn during the study period, and are included in this report. The infants w
ho demonstrated leukemoid reaction formed the study group, while the remain
der formed the control group. Leukemoid reaction was defined as a white blo
od cell (WBC) count greater than or equal to 50,000/mm(3). The relationship
between maternal and neonatal variables and WBC counts was studied. Nine o
f the 60 infants studied demonstrated counts >50,000/mm(3), with an inciden
ce of 15%. There was no significant association demonstrated between matern
al or neonatal variables and leukemoid reaction. Patients with leukemoid re
action had a better overall survival. Leukemoid reaction in ELBW infants is
a rare and recently documented phenomenon. In our study the incidence was
15%. Although many factors have been postulated as a cause of this phenomen
on, we could not demonstrate any relationship between these factors and hig
h WBC counts, including sepsis and the use of antenatal steroids, the two m
ost likely variables. It was interesting to note that the infants who were
able to mount a leukemoid response had a better chance of survival than tho
se who did not.